Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival

Journal of Clinical Investigation

Volumn 113, Issue 2, 2004, Pages 188-199

  Maes, Christa ^a   Stockmans, Ingrid ^a   Moermans, Karen ^a   Van Looveren, Riet ^a   Smets, Nico ^a   Carmeliet, Peter ^b   Bouillon, Roger ^a   Carmeliet, Geert ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c Onderwijs en Navorsing   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; VASCULOTROPIN; BROXURIDINE; COMPLEMENTARY DNA; MESSENGER RNA; MSI1H PROTEIN, XENOPUS; NERVE PROTEIN; RIBONUCLEOPROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; XENOPUS PROTEIN;

ANGIOGENESIS; ARTICLE; BONE GROWTH; CARTILAGE CELL; CELL MATURATION; CELL SURVIVAL; ENCHONDRAL OSSIFICATION; EPIPHYSEAL CARTILAGE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANGIOGRAPHY; ANIMAL; ANOXIA; BIOLOGICAL MODEL; BONE DEVELOPMENT; CARTILAGE; CELL DIFFERENTIATION; CELL DIVISION; CHEMISTRY; CYTOLOGY; EPIPHYSIS; GENETIC RECOMBINATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; MUTAGENESIS; NICK END LABELING; PATHOLOGY; PHENOTYPE; PROTEIN BINDING; VASCULARIZATION;

ANGIOGRAPHY; ANIMALS; ANOXIA; BONE DEVELOPMENT; BROMODEOXYURIDINE; CARTILAGE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CHONDROCYTES; DNA, COMPLEMENTARY; EPIPHYSES; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MODELS, BIOLOGICAL; MUTAGENESIS; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE TISSUE PROTEINS; PHENOTYPE; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINATION, GENETIC; RIBONUCLEOPROTEINS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOPUS PROTEINS;

EID: 1342289558     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200419383     Document Type: Article

References (40)

1. Pfander, D., Cramer, T., Schipani, E., and Johnson, R.S. 2003. HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes. J. Cell Sci. 116:1819-1826.
2. Schipani, E., et al. 2001. Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival. Genes Dev. 15:2865-2876.
3. Karsenty, G., and Wagner, E.F. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2:389-406.
4. Carmeliet, P. 2000. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:389-395.
5. Robinson, C.J., and Stringer, S.E. 2001. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114:853-865.
6. Neufeld, G., et al. 2002. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med. 12:13-19.
7. Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsbrun, M. 1998. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92:735-745.
8. Gerber, H.P., et al. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5:623-628.
9. Maes, C., et al. 2002. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mecb. Dev. 111:61-73.
10. Zelzer, E., et al. 2002. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development. 129:1893-1904.
11. Brighton, C.T. 1978. Structure and function of the growth plate. Clin. Orthop. 136:22-32.
12. Wirth, T., et al. 2002. The blood supply of the growth plate and the epiphysis: a comparative scanning electron microscopy and histological experimental study in growing sheep. Calcif Tissue Int. 70:312-319.
13. Cole, A.A., and Wezeman, F.H. 1985. Perivascular cells in cartilage canals of the developing mouse epiphysis. Am. J. Anat. 174:119-129.
14. Floyd, W.E., Zaleske, D.J., Schiller, A.L., Trahan, C., and Mankin, H.J. 1987. Vascular events associated with the appearance of the secondary center of ossification in the murine distal femoral epiphysis. J. Bone Joint Surg. Am. 69:185-190.
15. Rivas, R., and Shapiro, F. 2002. Structural stages in the development of the long bones and epiphyses: a study in che New Zealand white rabbit. J. Bone Joint Surg. Am. 84:85-100.
16. Holmbeck, K., et al. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell. 99:81-92.
17. Zhou, Z., et al. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase 1. Proc. Natl. Acad. Sci. U. S. A. 97:4052-4057.
18. Brashear, H.R. 1963. Epiphyseal avascular necrosis and its relation to longitudinal bone growth. J. Bone Joint Surg. Am. 45-A:1423-1438.
19. Trueta, J., and Amato, V.P. 1960. The vascular contribution to osteogenesis. III. Changes in the growth cartilage caused by experimentally induced ischaemia. J. Bone Joint Surg. Br. 42-B:571-587.
20. Flanigan, D.P., Keifer, T.J., Schuler, J.J., Ryan, T.J., and Castronuovo, J.J. 1983. Experience with Iatrogenic pediatric vascular injuries. Incidence, etiology, management, and results. Ann. Surg. 198:430-442.
21. Walter, P.K., and Hoffmann, W. 2000. Diminished epiphyseal growth following iatrogenic vascular trauma. Eur. J. Vast. Endovasc. Surg. 20:214-216.
22. Stalmans, I., et al. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J. Clin. Invest. 109:327-336. doi:10.1172/JCI200214362.
23. Ryan, H.E., Lo, J., and Johnson, R.S. 1998. HIF-1α is required for solid tumor formation and embryonic vascularization. EMBO J. 17:3005-3015.
24. Amling, M., et al. 1997. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136:205-213.
25. Semenza, G.L. 2000. HIF-1: mediator of physiological and pathophysiological responses to hypoxia J. Appl. Physiol. 88:1474-1480.
26. Tomita, Y., et al. 1986. The role of the epiphyseal and metaphyseal circulations on longitudinal growth in the dog: an experimental study. J. Hand Surg. [Am.]. 11:375-382.
27. Haigh, J.J., Gerber, H.P., Ferrara, N., and Wagner, E.F. 2000. Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development. 127:1445-1453.
28. Vu, T.H., et al. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:411-422.
29. Zachary, I., and Gliki, G. 2001. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49:568-581.
30. Gerber, H.P., et al. 2002. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 417:954-958.
31. Oosthuyse, B., et al. 2001. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28:131-138.
32. Nakagawa, M., et al. 2000. Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett. 473:161-164.
33. Bachelder, R.E., et al. 2001. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res. 61:5736-5740.
34. Dias, S., Shmelkov, S.V., Lam, G., and Rafii, S. 2002. VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition. Blood. 99:2532-2540.
35. Kronenberg, H.M. 2003. Developmental regulation of the growth plate. Nature. 423:332-336.
36. Kitsukawa, T., Shimono, A., Kawakami, A., Kondoh, H., and Fujisawa, H. 1995. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development. 121:4309-4318.
37. Behar, O., Golden, J.A., Mashimo, H., Schoen, F.J., and Fishman, M.C. 1996. Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature. 383:525-528.
38. Bagnard, D., et al. 2001. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J. Neurosci. 21:3332-3341.
39. Miao, H.Q., et al. 1999. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 146:233-242.
40. Soker, S., Miao, H.Q., Nomi, M., Takashima, S., and Klagsbrun, M. 2002. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J. Cell Biochem. 85:357-368.